//--> //--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~subject:"USA"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Agency rulemaking, political i...
Similar by person
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
USA
Arzneimittelrecht
11
Pharmaceutical law
11
United States
11
Arzneimittel
10
Pharmaceuticals
10
Pharmaceutical industry
5
Pharmaindustrie
5
Regulation
4
Regulierung
4
Arzneimittelmarkt
3
Food safety
3
Lebensmittelsicherheit
3
Pharmaceutical market
3
Public administration
3
USA / Food and Drug Administration
3
Öffentliche Verwaltung
3
1990-1995
2
Bürokratietheorie
2
Charges
2
Competition
2
Corporate finance
2
Dauer
2
Diversification
2
Diversifikation
2
Droge
2
Drug
2
Drug approval
2
Drug lag
2
Drug safety
2
Duration
2
Gebühr
2
Großbritannien
2
Political control
2
Theory of bureaucracy
2
Time
2
United Kingdom
2
Unternehmensfinanzierung
2
Verwaltungskontrolle
2
Wettbewerb
2
more ...
less ...
Type of publication
All
Article
10
Book / Working Paper
1
Type of publication (narrower categories)
All
Article in journal
9
Aufsatz in Zeitschrift
9
Language
All
English
11
Author
All
Olson, Mary K.
11
Published in...
All
Journal of economics & management strategy : JEMS
2
Journal of health economics
2
The journal of law, economics, & organization
2
Journal of risk and uncertainty : JRU
1
Regulation : the Cato review of business and government
1
Reinventing government and the problem of bureaucracy
1
The journal of law & economics
1
more ...
less ...
Source
All
ECONIS (ZBW)
11
Showing
1
-
10
of
11
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Substitution in regulatory agencies : FDA enforcement alternatives
Olson, Mary K.
- In:
The journal of law, economics, & organization
12
(
1996
)
2
,
pp. 376-407
Persistent link: https://www.econbiz.de/10001211623
Saved in:
2
The risk we bear : the effects of review speed and industry user fees on new drug safety
Olson, Mary K.
- In:
Journal of health economics
27
(
2008
)
2
,
pp. 175-200
Persistent link: https://www.econbiz.de/10003731055
Saved in:
3
Are novel drugs more risky for patients than less novel drugs?
Olson, Mary K.
- In:
Journal of health economics
23
(
2004
)
6
,
pp. 1135-1158
Persistent link: https://www.econbiz.de/10002461558
Saved in:
4
Pharmaceutical policy change and the safety of new drugs
Olson, Mary K.
- In:
The journal of law & economics
45
(
2002
)
2,2
,
pp. 615-642
Persistent link: https://www.econbiz.de/10001780852
Saved in:
5
Regulatory reform and bureaucratic responsiveness to firms : the impact of user fees in the FDA
Olson, Mary K.
- In:
Journal of economics & management strategy : JEMS
9
(
2000
)
3
,
pp. 363-395
Persistent link: https://www.econbiz.de/10001511812
Saved in:
6
Firm characteristics and the speed of FDA approval
Olson, Mary K.
- In:
Journal of economics & management strategy : JEMS
6
(
1997
)
2
,
pp. 377-401
Persistent link: https://www.econbiz.de/10001221830
Saved in:
7
Regulatory agency discretion among competing industries : inside the FDA
Olson, Mary K.
- In:
The journal of law, economics, & organization
11
(
1995
)
2
,
pp. 379-405
Persistent link: https://www.econbiz.de/10001193744
Saved in:
8
Explaining regulatory behavior in the FDA : political control vs. agency discretion
Olson, Mary K.
- In:
Reinventing government and the problem of bureaucracy
,
(pp. 71-108)
.
1996
Persistent link: https://www.econbiz.de/10001334378
Saved in:
9
Eliminating the US drug lag : implications for drug safety
Olson, Mary K.
- In:
Journal of risk and uncertainty : JRU
47
(
2013
)
1
,
pp. 1-30
Persistent link: https://www.econbiz.de/10010222448
Saved in:
10
How have user fees affected the FDA? : The 1992 FDA reform successfully reduced drug review times
Olson, Mary K.
- In:
Regulation : the Cato review of business and government
25
(
2002
)
1
,
pp. 20-25
Persistent link: https://www.econbiz.de/10001697480
Saved in:
1
2
Next
Last
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->